Charles Schwab Investment Management Inc. Sells 298,958 Shares of Centene Co. (NYSE:CNC)

Charles Schwab Investment Management Inc. reduced its position in Centene Co. (NYSE:CNC - Free Report) by 7.5% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 3,672,542 shares of the company's stock after selling 298,958 shares during the quarter. Charles Schwab Investment Management Inc. owned about 0.73% of Centene worth $276,469,000 at the end of the most recent quarter.

Several other large investors have also made changes to their positions in CNC. Park Place Capital Corp boosted its stake in shares of Centene by 1,190.0% in the 3rd quarter. Park Place Capital Corp now owns 387 shares of the company's stock valued at $29,000 after purchasing an additional 357 shares in the last quarter. WR Wealth Planners LLC grew its stake in shares of Centene by 41.4% during the second quarter. WR Wealth Planners LLC now owns 468 shares of the company's stock worth $31,000 after buying an additional 137 shares during the last quarter. Chris Bulman Inc acquired a new position in shares of Centene during the second quarter worth $33,000. Riverview Trust Co lifted its stake in shares of Centene by 154.6% in the 2nd quarter. Riverview Trust Co now owns 527 shares of the company's stock valued at $35,000 after acquiring an additional 320 shares during the last quarter. Finally, Thurston Springer Miller Herd & Titak Inc. acquired a new stake in Centene during the 2nd quarter worth approximately $36,000. Institutional investors and hedge funds own 93.63% of the company's stock.

Centene Stock Up 0.0 %

NYSE:CNC traded up $0.02 on Friday, hitting $60.37. The stock had a trading volume of 4,143,310 shares, compared to its average volume of 6,945,282. The company has a quick ratio of 1.10, a current ratio of 1.10 and a debt-to-equity ratio of 0.64. Centene Co. has a 52 week low of $57.20 and a 52 week high of $81.42. The business's fifty day moving average is $66.68 and its 200 day moving average is $70.50. The company has a market cap of $30.48 billion, a PE ratio of 10.48, a P/E/G ratio of 0.83 and a beta of 0.49.

Analyst Upgrades and Downgrades

CNC has been the subject of several analyst reports. Barclays dropped their price target on shares of Centene from $97.00 to $91.00 and set an "overweight" rating for the company in a research note on Tuesday, October 29th. Robert W. Baird lowered their price objective on Centene from $83.00 to $66.00 and set a "neutral" rating for the company in a research report on Friday, October 25th. Sanford C. Bernstein reduced their target price on Centene from $96.00 to $88.00 and set an "outperform" rating on the stock in a report on Wednesday, October 30th. Cantor Fitzgerald restated an "overweight" rating and set a $90.00 price target on shares of Centene in a report on Tuesday, October 1st. Finally, Deutsche Bank Aktiengesellschaft increased their price objective on shares of Centene from $82.00 to $87.00 and gave the stock a "hold" rating in a research report on Friday, August 2nd. Seven investment analysts have rated the stock with a hold rating and eight have issued a buy rating to the company's stock. According to data from MarketBeat, Centene presently has an average rating of "Moderate Buy" and a consensus price target of $83.92.

Insider Buying and Selling

In other Centene news, CEO Sarah London purchased 4,117 shares of the company's stock in a transaction that occurred on Friday, November 8th. The shares were acquired at an average cost of $60.80 per share, for a total transaction of $250,313.60. Following the completion of the acquisition, the chief executive officer now owns 667,229 shares of the company's stock, valued at $40,567,523.20. The trade was a 0.62 % increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, CFO Andrew Lynn Asher bought 17,200 shares of the firm's stock in a transaction dated Wednesday, November 13th. The shares were acquired at an average cost of $58.14 per share, with a total value of $1,000,008.00. Following the completion of the transaction, the chief financial officer now owns 486,847 shares in the company, valued at approximately $28,305,284.58. The trade was a 3.66 % increase in their ownership of the stock. The disclosure for this purchase can be found here. 0.33% of the stock is owned by company insiders.

About Centene

Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, commercial organizations, and military families in the United States. The company operates through Medicaid, Medicare, Commercial, and Other segments. The Medicaid segment offers health plan coverage, including medicaid expansion, aged, blind, disabled, children's health insurance program, foster care, medicare-medicaid plans, long-term services and support.